Wall Street analyst estimates for LCI Industries (LCII): consensus price target, buy/hold/sell recommendations and forecasts for revenue and EPS for the upcoming fiscal years.
LCI Industries, operating globally through its subsidiaries, specializes in producing and delivering a wide array of components for recreational vehicle (RV) manufacturers and various associated industries. The company's operations are divided into two primary divisions: Original Equipment Manufacturers (OEM) and Aftermarket.
Consensus price target
$105.67 (+7 % vs price $98.98)
between $80.00 and $120.00 · 7 targets published in the last quarter
Closing price, Oct 30
A twelve-month target is not a fair value: compare it with the range in the Valuation tab.
Revenue and EPS estimates
| Fiscal year | Revenue (average) | Revenue (low – high) | EPS (average) | Analysts |
|---|---|---|---|---|
| 2026E | $4.0B | $3.9B – $4.1B | $8.40 | 7 |
| 2027E | $4.1B | $4.0B – $4.3B | $9.21 | 7 |
Figures in USD · consensus as of October 30, 2026
Analyst Consensus
| Strong Buy | 0 |
| Buy | 4 |
| Hold | 9 |
| Sell | 2 |
| Strong Sell | 0 |
| Total analysts | 15 |
| Avg rating (−2 sell to +2 buy) | 0.13 |
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-11-05 | $2.06 | ||
| 2026-08-05 | $2.70 | $2.58 | +4.7% |
| 2026-03-31 | $2.60 | $2.17 | +19.8% |
| 2026-02-18 | $0.89 | $0.69 | +29.0% |
| 2025-10-30 | $1.97 | $1.44 | +36.8% |
| 2025-08-05 | $2.39 | $2.22 | +7.7% |
| 2025-05-06 | $2.19 | $1.55 | +41.3% |
| 2025-02-11 | $0.37 | $0.31 | +19.4% |
Valuation Ratios
| P/E Ratio | 11.51 |
| Price / Book | 1.68 |
| EV / EBITDA | 7.54 |
| Dividend Yield | 4.65% |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.68B | $2.15B | $2.48B | $2.37B | $2.80B | $4.47B | $5.21B | $3.78B | $3.74B | $4.12B |
| Cost of Revenue | $1.25B | $1.65B | $1.96B | $1.83B | $2.09B | $3.43B | $3.93B | $3.01B | $2.86B | $3.14B |
| Gross Profit | $428.9M | $493.1M | $520.3M | $539.2M | $706.1M | $1.04B | $1.27B | $776.2M | $879.7M | $980.3M |
| Research & Development | $9.0M | $4.7M | $16.0M | $14.0M | $13.0M | $17.0M | $26.0M | $20.0M | $21.0M | 0 |
| Selling, General & Admin | $209.1M | $254.2M | $295.0M | $310.2M | $435.7M | $584.8M | $657.2M | $588.0M | $601.5M | $495.3M |
| Operating Expenses | $228.1M | $278.8M | $321.6M | $339.0M | $483.2M | $644.6M | $720.3M | $652.8M | $661.5M | $700.4M |
| Operating Income | $200.8M | $214.3M | $198.8M | $200.2M | $222.9M | $398.4M | $553.0M | $123.4M | $218.2M | $279.9M |
| EBITDA | $247.0M | $269.0M | $266.3M | $273.7M | $320.9M | $513.0M | $682.2M | $255.2M | $343.9M | $412.0M |
| Interest Expense | $1.7M | $1.4M | $6.4M | $8.8M | $13.5M | $16.4M | $27.6M | $40.4M | $28.9M | $35.7M |
| Pre-tax Income | $199.2M | $212.8M | $192.4M | $191.4M | $209.5M | $382.0M | $525.5M | $83.0M | $189.3M | $255.1M |
| Income Tax | $69.5M | $80.0M | $43.8M | $44.9M | $51.0M | $94.3M | $130.5M | $18.8M | $46.5M | $66.8M |
| Net Income | $129.7M | $132.9M | $148.6M | $146.5M | $158.4M | $287.7M | $395.0M | $64.2M | $142.9M | $188.2M |
| EPS | $5.26 | $5.31 | $5.90 | $5.86 | $6.30 | $11.39 | $15.57 | $2.54 | $5.61 | $7.59 |
| EPS (Diluted) | $5.20 | $5.24 | $5.83 | $5.84 | $6.27 | $11.32 | $15.48 | $2.52 | $5.60 | $7.57 |
| Shares Outstanding (Diluted) | 24.9 M | 25.4 M | 25.5 M | 25.1 M | 25.3 M | 25.4 M | 25.5 M | 25.4 M | 25.5 M | 24.9 M |
Price
| Price | $98.98 (closing price, October 30, 2026) |
| Market Cap | $2.4B |
| Exchange | NYSE |
| Country | US |
Related companies: COLM · CAKE · GEF · ZGN · YETI · HOG
Explore sector: Consumer Cyclical · Auto - Recreational Vehicles
More sections of LCII: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks